WHO declares Ebola global emergency as death toll hits 87. Is there a vaccine? What we know

On 16 May 2026, the WHO Director-General declared the Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda a Public Health Emergency of In...

What Happened

On 16 May 2026, the WHO Director-General declared the Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda a Public Health Emergency of International Concern (PHEIC) under the International Health Regulations (IHR), 2005.
The declaration was made after consultation with the States Parties affected and follows the determination that the event constitutes a public health risk to other states through potential international spread.
The outbreak involves the Bundibugyo strain of Ebola — a rare variant with no approved vaccine and no licensed specific therapeutics.
As of 16 May 2026: 8 laboratory-confirmed cases, 246 suspected cases, and 80 suspected deaths in DRC's Ituri Province, across at least three health zones (Bunia, Rwampara, Mongbwalu). Two laboratory-confirmed cases (including one death) were reported in Kampala, Uganda, with no apparent epidemiological link between the two Kampala cases.
The WHO noted the outbreak may be spreading faster than detected, and stated that early supportive care remains the most lifesaving intervention available.

Static Topic Bridges

What is a PHEIC?

A Public Health Emergency of International Concern (PHEIC) is a formal declaration under Article 12 of the IHR (2005), representing the highest level of global health alert.

Definition (IHR 2005 Article 1): "An extraordinary event which is determined to constitute a public health risk to other States through the international spread of disease and to potentially require a coordinated international response."
The IHR 2005 replaced the earlier International Sanitary Regulations and came into force on 15 June 2007.
The WHO Director-General convenes an Emergency Committee (under Article 48, IHR 2005) of independent experts to assess evidence and advise on whether PHEIC criteria are met.
A PHEIC does not automatically mean a "pandemic" — the WHO Director-General separately determines whether a PHEIC constitutes a Pandemic Emergency under IHR amendments adopted in 2024.

Connection to this news: The 2026 DRC-Uganda Ebola (Bundibugyo) PHEIC is the ninth PHEIC declaration since the IHR 2005 came into force, and the first involving the Bundibugyo strain — triggering international coordination obligations for WHO member states.

PHEIC Declaration History (2009–2026)

H1N1 Influenza (Swine Flu) — April 26, 2009 (first PHEIC under IHR 2005; pandemic declared June 2009)
Polio — May 5, 2014 (declared ongoing; still active)
Ebola — West Africa — August 8, 2014 (Guinea, Sierra Leone, Liberia; ~11,000 deaths)
Zika Virus — February 1, 2016 (Americas; declared ended November 2016)
Ebola — Kivu, DRC — July 17, 2019 (declared ended June 2020)
COVID-19 — January 30, 2020 (declared ended May 5, 2023; pandemic declared March 11, 2020)
Mpox (2022) — July 23, 2022 (multi-country; declared ended May 11, 2023)
Mpox (2024) — August 14, 2024 (DRC-centred; clade Ib strain)
Ebola — Bundibugyo, DRC & Uganda — May 16, 2026

Connection to this news: India has twice been affected by PHEIC-related health alerts (COVID-19, Mpox 2022) and must maintain a robust IHR-compliant surveillance and response system — including at designated points of entry (airports and seaports) — during all active PHEICs.

Ebola Virus Disease — Taxonomy and Strains

Ebola Virus Disease (EVD) is caused by viruses belonging to the genus Ebolavirus within the family Filoviridae. It is classified as a Biosafety Level 4 (BSL-4) pathogen — the highest biosafety designation, requiring maximum containment laboratories for research.

There are six recognised Ebolavirus species: Zaire, Sudan, Bundibugyo, Taï Forest, Reston, and Bombali.
Zaire ebolavirus: Most deadly and most common in outbreaks; case fatality rate (CFR) 60–90%; responsible for the 2014–16 West Africa outbreak and the 2018–20 Kivu outbreak.
Bundibugyo ebolavirus: First identified in Bundibugyo District, western Uganda, in 2007; CFR approximately 36–40% — significantly lower than Zaire strain but still extremely severe.
Sudan ebolavirus: CFR ~40–65%; no approved vaccine as of 2026.
Transmission: direct contact with blood, secretions, organs, or other bodily fluids of infected persons or animals; no airborne transmission.
Fruit bats (Pteropodidae) are considered the natural reservoir host.

Connection to this news: The Bundibugyo strain's lower CFR compared to Zaire does not make it less urgent from a public health standpoint — the absence of any approved vaccine or therapeutic (unlike for Zaire, for which rVSV-ZEBOV/Ervebo is approved) makes outbreak control entirely dependent on isolation, contact tracing, and supportive care.

Vaccines and Therapeutics — Zaire vs. Bundibugyo

rVSV-ZEBOV (brand name: Ervebo): Approved by the US FDA (December 2019) and WHO-prequalified; effective against Zaire ebolavirus; not cross-protective against Bundibugyo or Sudan strains; used ring-vaccination strategy to end the 2018–20 Kivu outbreak.
Ad26.ZEBOV + MVA-BN-Filo (Zabdeno + Mvabea): Two-dose regimen; approved by the European Medicines Agency (EMA) for Zaire strain only.
No approved vaccine exists for the Bundibugyo, Sudan, or Taï Forest strains as of May 2026.
No specific licensed therapeutic exists for Bundibugyo EVD; experimental monoclonal antibodies developed for Zaire (e.g., Inmazeb/atoltivimab) have unknown cross-efficacy.
Treatment remains primarily supportive: oral or intravenous rehydration, maintaining oxygen and blood pressure, treating secondary infections.

Connection to this news: The absence of a Bundibugyo-specific vaccine is the single most consequential factor elevating the WHO's response level — it means ring-vaccination and post-exposure prophylaxis strategies available for Zaire outbreaks are unavailable, placing full weight on classical outbreak-containment measures.

International Health Regulations (IHR) 2005 — India's Obligations

India is a signatory to the IHR 2005. The regulations legally bind all 196 WHO Member States.
Under the IHR, States Parties must develop and maintain core capacities in surveillance, reporting, notification, verification, response, and coordination.
During a PHEIC, India is obligated to share relevant public health information with WHO and implement Temporary Recommendations issued by the Director-General.
India must maintain IHR-compliant measures at Points of Entry — international airports, ports, and ground crossings — including health screening, isolation facilities, and contact tracing for travellers.
India's Integrated Disease Surveillance Programme (IDSP) under the National Centre for Disease Control (NCDC) is the primary national surveillance infrastructure linked to IHR obligations.

Connection to this news: While the outbreak is currently confined to DRC's Ituri Province and Kampala, the confirmed cross-border spread to Uganda's capital underscores the risk of further international spread via air travel, making airport-level surveillance at Indian international airports a relevant precautionary measure.

Key Facts & Data

PHEIC declared: May 16, 2026 (WHO Director-General)
Ebola strain: Bundibugyo ebolavirus (first identified: Bundibugyo District, Uganda, 2007)
Affected areas: Ituri Province, DRC (Bunia, Rwampara, Mongbwalu health zones) + Kampala, Uganda
Confirmed cases: 8 lab-confirmed; 246 suspected; 80 suspected deaths (as of May 16, 2026)
Bundibugyo CFR: ~36–40% (vs. 60–90% for Zaire strain)
Vaccines: No approved vaccine for Bundibugyo strain (rVSV-ZEBOV/Ervebo covers Zaire only)
Therapeutics: No licensed specific treatment for Bundibugyo EVD
IHR (2005): Came into force June 15, 2007; 196 States Parties
Total PHEICs declared 2009–2026: 9 (including this declaration)
Ebola taxonomy: Family Filoviridae; Genus Ebolavirus; BSL-4 pathogen
Natural reservoir: Fruit bats (Pteropodidae — probable; not definitively confirmed)
India's IHR surveillance body: IDSP under National Centre for Disease Control (NCDC)